| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1090523221 |
| P356 | DOI | 10.1038/S41598-017-05226-Y |
| P932 | PMC publication ID | 5503987 |
| P698 | PubMed publication ID | 28694529 |
| P50 | author | Florian Lang | Q87017686 |
| P2093 | author name string | Frank Hirche | |
| Michael Föller | |||
| Bingbing Zhang | |||
| Martina Feger | |||
| Philipp Hase | |||
| Philipp Glosse | |||
| P2860 | cites work | Vitamin D receptor regulates TGF-β signalling in systemic sclerosis | Q87138864 |
| Vitamin D receptor in chondrocytes promotes osteoclastogenesis and regulates FGF23 production in osteoblasts | Q39076759 | ||
| Cross-talk between 1,25-dihydroxyvitamin D3 and transforming growth factor-beta signaling requires binding of VDR and Smad3 proteins to their cognate DNA recognition elements | Q43559930 | ||
| TGF-beta-induced Ca(2+) influx involves the type III IP(3) receptor and regulates actin cytoskeleton. | Q43948753 | ||
| TGFβ1 and SGK1-sensitive store-operated Ca2+ entry and Orai1 expression in endometrial Ishikawa cells | Q44814907 | ||
| Effect of different growth factors on human osteoblasts activities: a possible application in bone regeneration for tissue engineering. | Q46279041 | ||
| TGFbeta-mediated FGF signaling is crucial for regulating cranial neural crest cell proliferation during frontal bone development | Q46837830 | ||
| Enhanced FGF23 production in mice expressing PI3K-insensitive GSK3 is normalized by β-blocker treatment. | Q53810866 | ||
| Mutation of the mouse klotho gene leads to a syndrome resembling ageing | Q24328782 | ||
| TGF-β and BMP signaling in osteoblast, skeletal development, and bone formation, homeostasis and disease | Q26738766 | ||
| FGF23 in Acute and Chronic Illness | Q26778554 | ||
| Regulation and function of the FGF23/klotho endocrine pathways | Q26860470 | ||
| TGF-β and BMP signaling in osteoblast differentiation and bone formation | Q26995720 | ||
| 1,25-dihydroxyvitamin D(3) regulation of fibroblast growth factor-23 expression in bone cells: evidence for primary and secondary mechanisms modulated by leptin and interleukin-6 | Q28572351 | ||
| PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: a bone parathyroid feedback loop | Q28575895 | ||
| Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism | Q29620323 | ||
| Advanced glycation end products stimulate gene expression of fibroblast growth factor 23. | Q30313507 | ||
| Up-regulation of FGF23 release by aldosterone. | Q30315793 | ||
| NFκB-sensitive Orai1 expression in the regulation of FGF23 release | Q30315916 | ||
| A comparative transcriptome analysis identifying FGF23 regulated genes in the kidney of a mouse CKD model. | Q34412241 | ||
| FGF23 neutralization improves bone quality and osseointegration of titanium implants in chronic kidney disease mice | Q35065731 | ||
| Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease | Q35099518 | ||
| Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production | Q36863458 | ||
| TGF-beta type II receptor phosphorylates PTH receptor to integrate bone remodelling signalling | Q36991645 | ||
| Elevation in fibroblast growth factor 23 and its value for identifying subclinical atherosclerosis in first-degree relatives of patients with diabetes | Q37307040 | ||
| Energy-dense diets increase FGF23, lead to phosphorus retention and promote vascular calcifications in rats | Q37411895 | ||
| Post-translational regulation of TGF-β receptor and Smad signaling. | Q38012228 | ||
| TGF-β signalling and its role in cancer progression and metastasis | Q38020111 | ||
| Klotho, phosphate and FGF-23 in ageing and disturbed mineral metabolism | Q38115124 | ||
| TGF-β/BMP proteins as therapeutic targets in renal fibrosis. Where have we arrived after 25 years of trials and tribulations? | Q38614160 | ||
| TGF-β: the master regulator of fibrosis | Q38816052 | ||
| The cellular and signalling alterations conducted by TGF-β contributing to renal fibrosis | Q38947296 | ||
| Cardiac actions of fibroblast growth factor 23. | Q38977291 | ||
| FGF23-αKlotho as a paradigm for a kidney-bone network | Q39009569 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 4982 | |
| P577 | publication date | 2017-07-10 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | The production of fibroblast growth factor 23 is controlled by TGF-β2 | |
| P478 | volume | 7 |
| Q55220754 | GDF11 Modulates Ca2+-Dependent Smad2/3 Signaling to Prevent Cardiomyocyte Hypertrophy. |
| Q98944964 | Genome-wide association study for circulating fibroblast growth factor 21 and 23 |
| Q57570848 | Insulin suppresses the production of fibroblast growth factor 23 (FGF23) |
| Q64108981 | PKC regulates the production of fibroblast growth factor 23 (FGF23) |
| Q90439911 | Peroxisome proliferator-activated receptor α (PPARα)-dependent regulation of fibroblast growth factor 23 (FGF23) |
| Q58789309 | TGF-Beta Signaling in Bone with Chronic Kidney Disease |
Search more.